Corinne Curran, FNP-C

The assessment available on the Lttl website does not establish a provider–patient relationship. Clinical services are provided by independent networks of U.S.-licensed clinicians and providers who determine eligibility for treatment based on medical history and assessment responses. Providers retain full discretion to prescribe or decline medications, including compounded GLP-1 therapies.

Compounded medications offered through Lttl are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. Results may vary and depend on individual factors such as adherence, provider guidance, and lifestyle changes.

Lttl does not manufacture medications. Product appearance may differ from images shown. Lttl partners with certified U.S. pharmacies to support high standards of safety and quality.